News
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 17, 2019
Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today announced...
-
Oct 10, 2019
Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today provided...
-
Sep 11, 2019Fully integrated campaign expected to drive 6M+ impressions and over 20,000 entries in promotion to provide a complimentary CaverStem® procedure performed by Dr. Scott Sanderson, MD at one of the newest CaverStem® Centers of Excellence: Elite Health Hawaii
Creative Medical Technology Holdings (OTC-CELZ) reported today it has signed an agreement with Edge Media Network to introduce CaverStem® to their community in an integrated campaign spanning...
-
Sep 4, 2019Patients Who Underwent Patented Penile Regenerative Procedure Using Their Own Bone Marrow Concentrate will be Described in Peer Reviewed Paper
Creative Medical Technology Holdings (OTC-CELZ) reported today completion of data analysis and submission of a research paper describing a total of 140 patients treated with the CaverStem®...
-
Aug 5, 2019OTCQB Status and Accelerating Adoption
Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading clinical-stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today announced...